Online Oncology Days
Day 4 | Kidney Cancer

Online Oncology Days | Day 4 - April 20, 2022 | 7 pm (CEST) / 1 pm (EDT)

Kidney Cancer | Ultrasound/Interventional Oncology/CT

Diagnosis, Treatment and Follow-Up 

The increased use of abdominal imaging has resulted in an increase in the number of small renal incidentaloma in recent decades (1). Also, most renal cell carcinomas (RCC) are identified as incidental findings (2). Therefore dedicated diagnostic renal imaging is important for the characterization of renal tumors to facilitate treatment planning and follow-up. Today’s meeting will center imaging around RCC, from new imaging techniques assessing malignancies, to overcoming technical challenges in thermal ablation treatment, till discussing the best follow-up strategies for RCC.

This webinar occurs now in the past. The recording is available. Click here to watch it now.

Please accept marketing-cookies to watch this video.

  • Ultrasound Diagnosis and Guided Treatment of Kidney Tumors - Prof. Jean Michel Correas
  • RCC Treatment by Percutaneous Ablation: State-of-the-Art Treatment - Dr. Carlos Abath
  • The Role of CT in the Diagnosis and Follow-Up of Patients with Kidney Cancer - Prof. Catherine Roy
  • Live Q&A
Why should you attend?
  1. To understand how to use CEUS, SMI and Fusion technologies in Ultrasound for Renal Cell Carcinoma's.
  2. To learn how to perform thermal ablation on Renal Cell Carcinoma's Ultrasound-guided and CT-guided.
  3. To learn how possible complications can be solved quickly and professionally using all facets of the Angio-CT.
  4. To learn about new CT applications in the field of Renal Cell Carcinoma imaging.


Moderator & Speaker: Prof. Jean Michel Correas, MD, PhD
Necker-Enfants Malades (Necker Hospital)
Paris, France

Prof. Jean-Michel Correas is a Professor of Radiology at the Paris-Descartes University and is vice-chairman of the Department of Adult Radiology at Necker University Hospital, Paris, France. After spending two years in the USA, he got a PhD degree from the University of Tours under the supervision of Prof. Pourcelot on Ultrasound Contrast Agents evaluation. He was Visiting Professor of Radiology at the University of Toronto Department of Imaging Research under Prof. PN Burns supervision. He is deeply involved in the development of Ultrasound Contrast Imaging and Interventional Radiology. He is still developing the concept of multi-parametric US imaging, combining information provided by B-mode, color and Power Doppler Imaging, Micro-Doppler techniques, CEUS and SWE. After ablation of more than 200 hepatocellular carcinomas, he developed minimally invasive treatment of renal tumors, starting in 2002. He performed more than 1600 ablative procedures using radiofrequency, microwave and cryotherapy. Prof. Correas is President of the Ultrasound Group of the French Society of Radiology, President of the French-Speaking Society of Ultrasound as well as President of the French Federation of Ultrasound.

Presentation title: Ultrasound Diagnosis and Guided Treatment of Kidney Tumors
Renal tumors represent a growing issue, for both precise characterization and treatment. Ultrasound (US) is playing a key role not only in incidental detection of renal masses but also as a problem solver in the case of indeterminate diagnosis at contrast-enhanced CT or MRI. In a practical case-based presentation, Prof. Correas will show how the different US technologies, like tissue harmonic imaging, Advanced Dynamic Flow, Superb Microvascular Imaging, Contrast-enhanced US and Smart Fusion can be utilized for better identification and characterization, fast and precise insertion of thermal ablation probes for treatment, and assessment of complications and efficacy in the field of renal tumors.

Speaker: Dr. Carlos Abath, MD
Head of Department of Interventional Radiology and Endovascular Surgery
Real Hospital Português
Recife, Brazil

Dr. Carlos Abath holds a degree in Medicine from the Federal University of Pernambuco, with a medical residency in Radiology at the Radiological Center of Brasília, a specialization in Vascular and Interventional Radiology at MedImagem at the Hospital da Beneficência Portuguesa in São Paulo and in Therapeutic Neuroradiology at the Fondation Rothschild, Paris. He holds the title of specialist in Interventional Radiology and Endovascular Surgery at the Brazilian Society of Interventional Radiology and in Diagnostic and Therapeutic Neuroradiology. Full member of the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) and of the Cardiovascular and Interventional Radiology Society of Europe (CIRSE).

Presentation title: RCC Treatment by Percutaneous Ablation: State-of-the-Art Treatment

CT-guided percutaneous ablation has been offered more and more as a therapeutic alternative to surgery. Particularly to patients who are not optimal surgical candidates and patients with impaired renal function, to preserve as much as possible parenchyma. Thermal ablation allows an accurate and effective treatment with comparable oncologic outcomes to surgery, with the advantage of having an Angio-CT suite at hand to solve any possible complication directly.

Speaker: Prof. Catherine Roy, MD, PhD
Chair of the Department of Radiology
Strasbourg University Hospital
Strasbourg, France

Prof. Catherine Roy is a professor of Radiology graduated from the University of Strasbourg, France. She has been a fellow resident in Radiology during one year at the University of Montreal in different subspecialties of Radiology. She started her career in Strasbourg in the field of Uro-radiology. She was member of the European Society of Uro-radiology ESUR and president of the French group of Uroradiology named SIGU for 10 years. She has been promoted as the chair of the Department of Radiology in Strasbourg. She has been involved in many teaching courses in the field of Uro-oncology.

Presentation title: The Role of CT in the Diagnosis and Follow-Up of Patients with Kidney Cancer
CT is the gold standard imaging modality for kidney cancer both for detection and screening before treatment, as well as for the follow-up of metastatic disease. The goal of this presentation is to present new CT applications in the field of kidney cancer. Spectral CT imaging on a wide-area detector CT scanner with Deep Learning Reconstruction allows for excellent image quality at a reasonable radiation dose. The new imaging parameters such as the iodine load quantification, the virtual non-contrast images, and the modulation of the injected contrast on monochromatic images result in an improvement of tissue characterization and a better evaluation of the tumoral extension. This improves diagnostic confidence when analyzing complex cases that demand focus on the details. Another modality that can be used in the follow-up to detect or eliminate the metastatic disease is Subtraction CT.

Scientific Evidence: Kidney Cancer | Ultrasound/Interventional Oncology/CT

Download scientific evidence on oncology solutions using Canon technologies here.


Yiran Mao et al. | The value of superb microvascular imaging in differentiating benign renal mass from malignant renal tumor: a retrospective study | Br J Radiol (2018)

Interventional Oncology

Miyuki Sone et al. | Angio-CT-Assisted Balloon Dissection: Protection of the Adjacent Intestine during Cryoablation for Patients with Renal Cancer | J Vasc Interv Radiol (2016).

Adrian Kobe et al. | Thermal Ablation Combined with Selective Transarterial Embolization of Centrally Located Renal Cell Carcinomas Measuring 3 cm or Larger | Cardiovasc Intervent Radiol (2022)


Ryo Matsukiyo et al. | Deep learning‑based and hybrid‑type iterative reconstructions for CT: comparison of capability for quantitative and qualitative image quality improvements and small vessel evaluation at dynamic CE‑abdominal CT with ultra‑high and standard resolutions | Jpn J Radiol (2021)

Other webinars that may interest you

Multimodality Webinars Oncology Webinars


  1. O’Connor SD, et al. | Incidental finding of renal masses at unenhanced CT: Prevalence and analysis of features for guiding management | Am J Roentgenol. (2011)
  2. Jayson M, et al. | Increased incidence of serendipitously discovered renal cell carcinoma | Urology. (1998)


  • The opinions expressed in this material are solely those of the presenter and not necessarily those of Canon Medical Systems. Canon Medical Systems does not guarantee the accuracy or reliability of the information provided herein.
  • The clinical results, performance and views described in this video/webinar are the experience of the clinician. Results may vary due to clinical setting, patient presentation and other factors. Many factors could cause the actual results and performance of canon Medical’s products to be materially different from any of the aforementioned.
  • Some products shown might not be available in all regulatory jurisdictions, please consult with your local Canon sales office for availability in your region.

Contact Us